Global Brand Lead, Epilepsy — Launch & Growth

UCB

Brussel

Hybrid

EUR 180,000 - 240,000

Full time

4 days ago

Be an early applicant

A complete application in a minute

Tailored resume and cover letter, ready to send.

Get past ATS filters

Job summary

UCB, a global biopharmaceutical company, seeks a Global Brand Head Epilepsy Brands to maximize the value of BRIVIACT, VIMPAT, KEPPRA and NAYZILAM. You will shape robust commercial strategies, drive lifecycle and launch excellence, and translate insights into strategic decisions to support sustainable growth in epilepsy care.

You will collaborate across Commercial, Medical, Market Access, Supply, Regulatory, HEOR and Insights, driving alignment and execution.

Qualifications

Extensive experience in pharmaceutical, biotechnology, or medical device industry.
Several years’ country or regional leadership experience
Strong global marketing, strategic planning, commercialization, and launch experience.
Proven cross-functional leadership, influencing, communication, and relationship-building capabilities.
Experience developing global strategies, business cases, and complex projects.

Responsibilities

Lead global commercial strategies across UCB’s epilepsy brand portfolio.
Drive launch, lifecycle, and integrated strategic planning across markets.
Translate patient, customer, and market insights into growth opportunities.
Align cross-functional stakeholders around portfolio priorities and coordinated execution.
Guide forecasting, investment decisions, risk mitigation, and performance optimization.
Advance digital, AI-driven, and innovative commercialization approaches globally.